Brief: Allarity Therapeutics Says James Cullem Terminated As Chief Executive Officer
Dec 11 (Reuters) - Allarity Therapeutics Inc ALLR.O :
* ALLARITY THERAPEUTICS INC - ON DECEMBER 8, 2023, MR. JAMES
CULLEM WAS TERMINATED AS CHIEF EXECUTIVE OFFICER OF ALLARITY
THERAPEUTICS
* ALLARITY THERAPEUTICS INC - ON DECEMBER 8, THOMAS JENSEN,
WAS
APPOINTED BY COMPANY'S BOARD OF DIRECTORS AS CHIEF EXECUTIVE
OFFICER
Source text for Eikon: [ID:https://bit.ly/3RBphl0]
Further company coverage: ALLR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic